Armored & Combination TAC-T Development Services

Online Inquiry

Background Service Service Packages Workflow Highlights FAQs Contact

The development of effective solid tumor immunotherapies faces major challenges, including severe on/off-target toxicities, poor T-cell infiltration, and rapid functional exhaustion within the immunosuppressive tumor microenvironment (TME). Creative Biolabs' Armored & Combination TAC-T Development Services are designed to systematically overcome these barriers. We provide an integrated platform that combines the engineering of intrinsically resistant TAC constructs with high-fidelity preclinical functional validation. This enables us to deliver optimized, multi-mechanism therapeutic candidates with de-risked efficacy and enhanced durability, accelerating your path to a clinically viable and potent cell therapy product.

Introduction

TAC-T Development refers to the end-to-end process of designing, engineering, and validating T Cell Antigen Coupler-based therapies, which reprogram T cells to target tumors via co-option of the endogenous TCR complex. Armored & Combination TAC-T Development systematically advances this core platform by integrating supplementary genetic modules to confer resistance to the immunosuppressive tumor microenvironment, thereby creating multi-functional, next-generation therapeutic candidates.

Fig.1 Engineering armored & combinatorial T cell antigen coupler platforms. (Creative Biolabs Original) Fig.1 Development of armored and multi-mechanism TAC-T therapies.

Our Services

Creative Biolabs provides an integrated development platform engineered to translate your therapeutic vision into a clinically viable product. We harness the unique advantages of TAC technology, which recruits the native TCR signaling machinery for a more physiologically regulated T-cell response. Our advanced armoring strategies further fortify these cells through the targeted integration of genetic modules, empowering them to overcome the formidable barriers of solid tumors.

Service Packages

To overcome the fundamental challenges of solid tumor immunotherapy, we provide integrated development services that encompass both molecular engineering and predictive functional analysis. Our platform ensures your TAC-T candidates are both intrinsically armored and rigorously validated for clinical success.

TME Resistant TAC Construct Design & Construction Service

This service focuses on engineering the foundational molecular architecture of TAC-T cells to withstand the hostile solid tumor microenvironment. We design and build next-generation constructs by integrating proprietary modules that enhance metabolic fitness, resist exhaustion, and bypass immunosuppressive signals. The outcome is a clinically translatable, armored TAC-T candidate intrinsically equipped to maintain potency and persistence against complex in vivo barriers.

TME Penetration & Functional Analysis Service for TAC Therapy

This service provides a high-fidelity, preclinical evaluation platform to quantify how effectively engineered TAC-T cells infiltrate and function within biologically accurate solid tumor models. Utilizing patient-derived organoids, advanced microfluidic systems, and multi-omics readouts, we deliver predictive data on infiltration depth, spatial distribution, and sustained cytotoxic activity. The analysis identifies critical performance bottlenecks and validates the functional superiority of armored constructs in a physiologically relevant context.

Our Service Process

Required Starting Materials:

Target antigen sequence.
Lead binder candidates.

Key Steps:

Workflow of armored & combination TAC-T development services at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Analytical Validation Reports.
Purified Vector Stocks.
Functional Engineered Cell Batches.

Key Advantages

Bespoke Armoring Payload Design: We engineer TAC-T cells to express tailored therapeutic payloads, such as immunomodulatory cytokines, chemokines, or checkpoint inhibitor fragments, to actively reprogram the immunosuppressive tumor niche.
Precision-Tuned TCR Co-opting Domains: We select and optimize TCR recruitment domains from a proprietary library to calibrate signaling strength, ensuring optimal activation for your specific target antigen.
Intrinsic Metabolic Resilience Engineering: We integrate genetic modules designed to enhance cellular metabolic plasticity, enabling TAC-T cells to sustain energetic and biosynthetic activity within the hostile, nutrient-scarce tumor microenvironment.

FAQs

Q1: How does the mechanism of T-cell activation in TAC-T therapy differ from that in conventional CAR-T?

A1: TAC-T therapy is distinguished by its ability to specifically recruit and leverage the patient's endogenous TCR-CD3 signaling complex for target recognition and activation. In contrast, conventional CAR-T cells rely on a fully synthetic intracellular signaling tail, which lacks the natural regulatory mechanisms of the native TCR. This synthetic pathway is prone to ligand-independent "tonic signaling," a state of chronic activation that drives premature T-cell differentiation, metabolic stress, and functional exhaustion, limiting therapeutic persistence. TAC-T activation, by mirroring physiological signaling kinetics, mitigates this risk.

Q2: Does your service support the integration of customized functional modules for specialized "armoring"?

A2: Yes, we specialize in developing fully tailored armoring strategies. Our platform can design and integrate a wide range of functional genetic payloads, such as immunomodulatory cytokines, TME-modifying enzymes, or inhibitory receptor decoys, directly into the TAC-T construct. The design is informed by and optimized for your specific target antigen and the unique immunosuppressive profile of the intended tumor indication, thereby creating a bespoke therapy with enhanced fitness and resistance.

Why Choose Us?

We are pioneers in engineered T-cell biology, offering an integrated platform that uniquely addresses the core failures of conventional therapies. Our TAC technology eliminates unnatural tonic signaling, and our specialized armoring strategies confer intrinsic resistance to the hostile tumor microenvironment. This combination delivers candidates with superior metabolic fitness, persistence, and solid tumor efficacy, accelerating your path to clinical success.

How to contact us?

Creative Biolabs delivers a transformative development platform for next-generation solid tumor cell therapies. We uniquely integrate the physiological safety profile of TAC technology with targeted armoring strategies to overcome immunosuppressive barriers, creating potent and persistent therapeutic candidates.

Contact our scientific team to design a tailored development path for your project.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.